AN2 Therapeutics (ANTX) Cash from Investing Activities (2021 - 2026)
AN2 Therapeutics (ANTX) posted Cash from Investing Activities of -$3.66 million for Q2 2026, compared with $5.83 million a year earlier.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Cash from Investing Activities (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Investing Activities at AN2 Therapeutics was $17.91 million, down 33.3% year-over-year; for FY2025, it came in at $28.31 million, down 48.1% from FY2024.
- In prior years, AN2 Therapeutics' Cash from Investing Activities was $54.59 million in FY2024, -$43.28 million in FY2023, -$21.77 million in FY2022 and -$50.02 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Cash from Investing Activities since Q4 2024.
- The strongest year-over-year quarter for Cash from Investing Activities in the past five years was Q1 2024, with growth of 141.5%; the weakest was Q4 2023, with a decline of 93.1%.
- According to Business Quant data, Cash from Investing Activities for the three prior quarters was $8.29 million (Q1 2026), $7.17 million (Q4 2025) and $6.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | AN2 Therapeutics | 207.32 Mn | 207.32 Mn | - | -3.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.66 Mn |
| Mar 31, 2026 | 8.29 Mn |
| Dec 31, 2025 | 7.17 Mn |
| Sep 30, 2025 | 6.11 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Mar 31, 2025 | 9.19 Mn |
| Dec 31, 2024 | -6.88 Mn |
| Sep 30, 2024 | 18.72 Mn |
| Jun 30, 2024 | 16.46 Mn |
| Mar 31, 2024 | 26.29 Mn |
| Dec 31, 2023 | 420,000.00 |
| Sep 30, 2023 | -62.46 Mn |
| Jun 30, 2023 | 7.88 Mn |
| Mar 31, 2023 | 10.89 Mn |
| Dec 31, 2022 | 6.06 Mn |
| Sep 30, 2022 | -2.32 Mn |
| Jun 30, 2022 | -39.49 Mn |
| Mar 31, 2022 | 13.98 Mn |
| Dec 31, 2021 | 6.25 Mn |
| Sep 30, 2021 | -6.99 Mn |
API Access
AN2 Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();